Drug
insulin aspart-fsan
Marketed as GARZULYS.
Generic name
insulin aspart-fsan
Brand names
GARZULYS
First FDA approval
2026-07-24
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761497 | GARZULYS | 2026-07-24 | EMERGE BIOSCIENCE PTE. LTD. |
Manufacturers
EMERGE BIOSCIENCE PTE. LTD.
Frequently asked questions
When was insulin aspart-fsan FDA approved?
Earliest FDA approval on record: 2026-07-24.
What brand names are sold as insulin aspart-fsan?
GARZULYS.
Sources
Appeal a insulin aspart-fsan denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com